Lightspeed stories

Emergent unveils Wingman, an always-on AI agent for email, scheduling and sales support as Australian firms seek to ease admin pressure.

Emergent's Wingman puts autonomous AI agents to work across email, calendars and chats, with human approval for higher-risk actions.

Emergent's Wingman promises an always-on digital assistant that can juggle email, calendars and chat, while pausing for approval on bigger actions.

Lightspeed has unveiled an AI tool in its retail platform that scans supplier documents into draft purchase orders to cut errors and admin time.

London fintech Stacks raises USD $23m to scale AI-driven finance automation as it launches Flux tool for faster close and reporting.

Emergent launches mobile app for its AI software builder after hitting USD $100m annual run rate and doubling revenue in just one month.

Aspire partners with early-stage investor Antler to capture global founders at inception, targeting a 2.3x jump in startup customers by 2026.

AI platform Emergent raises USD $70m Series B from Khosla Ventures and SoftBank to speed global software creation for non-coders.

AI app builder Emergent raises USD $70m Series B to deepen European push, add London offices and hiring as revenue soars to USD $50m ARR.

Google has invested in Emergent, giving the AI start-up early access to Gemini 3 to help millions of non-coders build production software.

Singapore fintech Aspire wins key licences in Australia, Europe and the US, paving the way for a global rollout of its business finance platform.

Mstack launches Chemstack AI, an AI-driven platform cutting chemical synthesis and commercialisation from 18 months to days amid supply chain woes.

VivaTech 2025 attracted 180,000 global visitors, highlighting a 40% surge in AI exhibitors and fostering 640,000 business connections across 171 nationalities.

Endor Labs secures strategic investment from Citi Ventures, boosting its mission to protect software supply chains for major financial institutions.

Triomics secures $15 million in Series A funding to revolutionise oncology workflows in the US with AI tech, speeding clinical trial matching and patient care.